InCarda Therapeutics, Inc.
Formerly Pleiades Cardio-Therapeutics, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
InCarda Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2020).
SEC Form D · Oct 2020
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Oct 2020
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of InCarda Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Grace Colon | Executive officer | Oct 2020 |
| Miller Samantha | Executive officer | May 2017 |
| Rangachari Narasimhan | Executive officer | May 2017 |
| Alan Colowick | Director | Oct 2020 |
| Andrew ElBardissi | Director | Oct 2020 |
| Dan Welch | Director | Oct 2020 |
| Grace Colon | Director | Oct 2020 |
| Isaac Cheng | Director | Oct 2020 |
| Johan Christenson | Director | Oct 2020 |
| Bischofberger Norbert | Director | Nov 2019 |
| McCarthy Reenie | Director | May 2017 |
| Rangachari Narasimhan | Director | May 2017 |